Found 277 matching trials
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial PHASE2 The goal of this pilot clinical trial is to determine the effectiveness of ...
Show More Status
Active Not Recruiting
Location
Vanderbilt University Medical Center
Learn More & Join Trial
A Study of a Weight Loss Intervention in People With Endometrial Cancer EARLY_PHASE1 The researchers are doing this study is to find out whether tirzepatide and...
Show More Location
Memorial Sloan Kettering Basking Ridge
Learn More & Join Trial
Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data N/A Investigators are building an empirical evidence base for real world data t...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists. N/A Obesity is a chronic multifactorial disease with a strong genetic component...
Show More Location
Laiko General Hospital, Athens
Learn More & Join Trial
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone PHASE3 The goal for this study is to evaluate the efficacy and safety of tirzepati...
Show More Location
National Research Institute
Learn More & Join Trial
Study of Patients Being Treated With Anti-obesity Medication N/A The goal of this observational study is to learn about the real-world effec...
Show More Location
Texas Tech University
Learn More & Join Trial
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients PHASE4 The purpose of this study is to use diet and an injectable medication calle...
Show More Location
University of Miami
Learn More & Join Trial
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight PHASE3 The main purpose of this study is to demonstrate that when participants wit...
Show More Location
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Avondale
Learn More & Join Trial
Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue PHASE1 Obesity and type 2 Diabetes Mellitus prevalence has doubled in the last 30 ...
Show More Location
Internal Medicine, College of Medicine and Health Sciences
Learn More & Join Trial
Spartina® (Tirzepatide) Effectiveness and Safety Evaluation N/A The goal of this study is to evaluate Effectiveness and safety of Spartina®...
Show More Location
Akbar Aliasgarzadeh Clinic
Learn More & Join Trial